Zannad F - Search Results

1

Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies.

Zannad F, Fay R. Zannad F, et al. Fundam Clin Pharmacol. 2007 Apr;21(2):181-90. doi: 10.1111/j.1472-8206.2007.00464.x. Fundam Clin Pharmacol. 2007. PMID: 17391291 Review.

2

Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.

Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F; CIC General Practitioners Investigators' Group. Radauceanu A, et al. Among authors: zannad f. Fundam Clin Pharmacol. 2004 Aug;18(4):483-91. doi: 10.1111/j.1472-8206.2004.00269.x. Fundam Clin Pharmacol. 2004. PMID: 15312156 Clinical Trial.

3

Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group.

Zannad F, Bernaud CM, Fay R. Zannad F, et al. J Hypertens. 1999 Jan;17(1):137-46. doi: 10.1097/00004872-199917010-00020. J Hypertens. 1999. PMID: 10100105 Clinical Trial.

4

Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Youcef G, Olivier A, Nicot N, Muller A, Deng C, Labat C, Fay R, Rodriguez-Guéant RM, Leroy C, Jaisser F, Zannad F, Lacolley P, Vallar L, Pizard A. Youcef G, et al. Among authors: zannad f. Br J Pharmacol. 2016 Jun;173(11):1805-19. doi: 10.1111/bph.13479. Epub 2016 Apr 26. Br J Pharmacol. 2016. PMID: 26990406 Free PMC article.

5

[Performance evaluation of a tool for institutional protocol quality assurance].

Zanetti L, Radauceanu A, Fay R, Essevaz-Roulet M, Lefèvre N, Zannad F. Zanetti L, et al. Among authors: zannad f. Therapie. 2005 Nov-Dec;60(6):527-37. doi: 10.2515/therapie:2005074. Therapie. 2005. PMID: 16555489 Clinical Trial. French.

6

Time-effect profile of antihypertensive agents assessed with trough/peak ratio, smoothness index and dose omission: an ambulatory blood pressure monitoring study with trandolapril vs. quinapril.

Radauceanu A, Virion JM, Boivin JM, Zannad F. Radauceanu A, et al. Among authors: zannad f. Fundam Clin Pharmacol. 2002 Dec;16(6):545-54. doi: 10.1046/j.1472-8206.2002.00131.x. Fundam Clin Pharmacol. 2002. PMID: 12685514 Clinical Trial.

7

Calcium antagonists and thiazide diuretics have opposite effects on blood rheology and radial artery compliance in arterial hypertension: a randomized double-blind study.

Khder Y, Bray des Boscs L, el Ghawi R, Meilhac B, Montestruc F, Stoltz JF, Zannad F. Khder Y, et al. Among authors: zannad f. Fundam Clin Pharmacol. 1998;12(4):457-62. doi: 10.1111/j.1472-8206.1998.tb00972.x. Fundam Clin Pharmacol. 1998. PMID: 9711470 Clinical Trial.

8

Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.

Olivier A, Girerd N, Michel JB, Ketelslegers JM, Fay R, Vincent J, Bramlage P, Pitt B, Zannad F, Rossignol P; EPHESUS Investigators. Olivier A, et al. Among authors: zannad f. Int J Cardiol. 2017 Aug 15;241:344-350. doi: 10.1016/j.ijcard.2017.02.018. Epub 2017 Feb 8. Int J Cardiol. 2017. PMID: 28284500 Clinical Trial.

9

Assessment of drug efficacy using home self-blood pressure measurement: the SMART study. Self Measurement for the Assessment of the Response to Trandolapril.

Zannad F, Vaur L, Dutrey-Dupagne C, Genès N, Chatellier G, Elkik F, Ménard J. Zannad F, et al. J Hum Hypertens. 1996 Jun;10(6):341-7. J Hum Hypertens. 1996. PMID: 8872795

10

Pharmacogenomics in cardiovascular clinical trials.

Shah R, Darne B, Atar D, Abadie E, Adams KF, Zannad F; 5th Cardiovascular Clinical Trialists Workshop. Shah R, et al. Among authors: zannad f. Fundam Clin Pharmacol. 2004 Dec;18(6):705-8. doi: 10.1111/j.1472-8206.2004.00289.x. Fundam Clin Pharmacol. 2004. PMID: 15548243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,213 results

Search Page

Filters